Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Mallinckrodt plc

MNKAMEX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.34
$-0.06(-14.97%)
U.S. Market is Open • 12:53

Mallinckrodt plc (MNK) Stock Overview

Explore Mallinckrodt plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.5M
P/E Ratio0.05
EPS (TTM)$-0.78
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

MNK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mallinckrodt plc (MNK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.05 and a market capitalization of 4.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
207.32%
1-Month Change
-14.97%
3-Month Change
-74.03%
6-Month Change
-95.77%
Year-to-Date (YTD) Change
-95.62%
1-Year Change
-97.80%
3-Year Change
-97.80%
5-Year Change
-97.80%
All-Time (Max) Change
-97.80%

Contact Information

353 1 696 0000
College Business & Technology Park, Dublin, NaN, 15

Company Facts

26,730 Employees
IPO DateJun 21, 2022
CountryIE

Frequently Asked Questions